This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
N-Acetylcysteine + Taurine is an anti-diabetic medication developed by the U.S. Food And Drug Administration and initially approved for treating diabetic kidney disease.
Mechanism of Action of undefined
N-Acetylcysteine + Taurine helps to treat diabetic kidney disease, a condition that can occur as a result of diabetes or a sudden increase in blood sugar levels. If left untreated, diabetic kidney disease can progress to kidney failure. This drug is commonly used to treat lung diseases such as chronic bronchitis, as it helps break down and thin mucus in the airways, making it easier to cough up. Additionally, N-Acetylcysteine acts as a protective agent against certain pharmaceutical drugs, such as paracetamol (acetaminophen), by helping to prevent liver damage caused by overdose or toxicity.
Uses of undefined
N-Acetylcysteine and Taurine work by slowing down the process of kidney cell damage and improving kidney function. These tablets are particularly beneficial in preventing the progression of microalbuminuria (the presence of small amounts of albumin in the urine) in patients with diabetic kidney disease.
undefined Drug administaration and Dosage available
Take the N-Acetylcysteine + Taurine Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Warnings, Precautions and Side Effects of undefined
Warnings
This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its component. The use of N-Acetylcysteine + Taurine should be avoided with topical antibiotics for the relief of dry eye syndrome. Combining this medicine with topical antibiotics can increase the risk of severe adverse reactions. It is important to consult your physician to determine the appropriate treatment options for keratoconjunctivitis and dry eye syndrome.
Precautions
It is important to note that this medicine is not recommended for use in patients experiencing a severe and sudden asthma attack. During treatment with this medicine, asthma patients should be closely monitored. Notify your physician if you develop any symptoms related to it. Inform your doctor of any heart, thyroid, kidney, or liver disease. Your physician may prescribe you a low dose and perform regular blood tests. It is generally recommended to avoid using N-Acetylcysteine + Taurine during pregnancy and breastfeeding unless it is necessary.
Side Effects
The side effects known to occur commonly during the treatment with N-Acetylcysteine + Taurine are nausea, vomiting, diarrhoea, fever, runny nose, abdominal pain, pain at the site of injection, breathing difficulty and drowsiness. Some serious side effects also include skin irritation and rashes, throat irritation, chest tightness, hives and wheezing, blood in cough, swelling and soreness inside the mouth.
Word Of Advice
If you have diabetes, regularly monitor your blood sugar levels while taking the medication, as it may interfere with your blood glucose levels. Ensure you maintain adequate hydration throughout the treatment, as both N-Acetylcysteine + Taurine may impact fluid balance in the body. If the medication is part of a broader treatment plan for diabetic kidney disease or other conditions, follow any lifestyle changes your physician recommends, such as dietary modifications and exercise routines.
Frequently Asked Question
References
- Hospimax, [Accessed on 30th June 2023], http://www.hospimax.com/formulation/Alcysta%20website%20content.pdf
- La Renon Healthcare Pvt. Ltd, [Accessed on 30th June 2023], https://www.larenon.com/wp-content/uploads/2019/07/3.-Soihenz.pdf
- J. Goddard, A.N. Turner, Kidney, and urinary tract disease, Davidson's Principles & Practice of Medicine, 22nd Edition, 2014, 461-523.
- E.R. Pearson, R.J. McCrimmon, Diabetes mellitus, Davidson's Principles & Practice of Medicine, 22nd Edition, 2014, 797-836.
Disclaimer
The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you are eligible to receive this treatment.
